Hypoglycaemia risk with insulin glargine 300 U/
            mL
            compared with glargine 100 U/
            mL
            across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the
            EDITION
            3 trial

Geremia B. Bolli; Wolfgang Landgraf; Zsolt Bosnyak; Lydie Melas‐Melt; Philip D. Home

doi:10.1111/dom.14065

Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14065 ◽

2020 ◽

Vol 22 (9) ◽

pp. 1664-1669

Author(s):

Geremia B. Bolli ◽

Wolfgang Landgraf ◽

Zsolt Bosnyak ◽

Lydie Melas‐Melt ◽

Philip D. Home

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Author response for "Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial"

10.1111/dom.14065/v2/response1 ◽

2020 ◽

Author(s):

Geremia B. Bolli ◽

Wolfgang Landgraf ◽

Zsolt Bosnyak ◽

Lydie Melas‐Melt ◽

Philip D. Home

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Author Response ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Decision letter for "Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial"

10.1111/dom.14065/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Review for "Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial"

10.1111/dom.14065/v1/review2 ◽

2020 ◽

Author(s):

Andrea Giaccari

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Review for "Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial"

10.1111/dom.14065/v2/review1 ◽

2020 ◽

Author(s):

Andrea Giaccari

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Decision letter for "Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial"

10.1111/dom.14065/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Review for "Hypoglycaemia risk with insulin glargine 300 U/ mL compared with glargine 100 U/ mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: a post hoc analysis of the EDITION 3 trial"

10.1111/dom.14065/v1/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

C Peptide ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Weight loss in patients with type 2 diabetes receiving once‐weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post‐hoc analysis of the AWARD‐4 study across baseline body mass index subgroups

Diabetes Obesity and Metabolism ◽

10.1111/dom.13658 ◽

2019 ◽

Vol 21 (6) ◽

pp. 1340-1348 ◽

Cited By ~ 6

Author(s):

Martin Fuechtenbusch ◽

Jens Aberle ◽

Elke Heitmann ◽

Claudia Nicolay ◽

Heike Jung

Keyword(s):

Type 2 Diabetes ◽

Body Mass Index ◽

Weight Loss ◽

Insulin Glargine ◽

Body Mass ◽

Insulin Lispro ◽

Baseline Body Mass Index ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Review for "Effect of Once Weekly Dulaglutide versus Insulin Glargine in Patients with Type 2 Diabetes and Different Baseline Glycaemic Patterns: A Post‐Hoc Analysis of the AWARD‐2 Clinical Trial"

10.1111/dom.13844/v3/review2 ◽

2019 ◽

Author(s):

Johan Jendle

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Review for "Effect of Once Weekly Dulaglutide versus Insulin Glargine in Patients with Type 2 Diabetes and Different Baseline Glycaemic Patterns: A Post‐Hoc Analysis of the AWARD‐2 Clinical Trial"

10.1111/dom.13844/v3/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text

Review for "Effect of Once Weekly Dulaglutide versus Insulin Glargine in Patients with Type 2 Diabetes and Different Baseline Glycaemic Patterns: A Post‐Hoc Analysis of the AWARD‐2 Clinical Trial"

10.1111/dom.13844/v2/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Post Hoc Analysis ◽

Post Hoc

Download Full-text